Back to Search
Start Over
Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
- Source :
-
Scandinavian journal of infectious diseases [Scand J Infect Dis] 2010; Vol. 42 (1), pp. 57-60. - Publication Year :
- 2010
-
Abstract
- A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2% were resistant to ciprofloxacin and 38.0% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Campylobacter isolation & purification
Child
Child, Preschool
Drug Resistance, Bacterial
Female
Germany
Hospitals, University
Humans
Infant
Infant, Newborn
Male
Microbial Sensitivity Tests
Middle Aged
Young Adult
Anti-Bacterial Agents pharmacology
Campylobacter drug effects
Campylobacter Infections microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1651-1980
- Volume :
- 42
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scandinavian journal of infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 20055727
- Full Text :
- https://doi.org/10.3109/00365540903283723